Publication - Abstract
Dec 21, 2017
Journal of Infectious Diseases
M. Meyer, E. Huang, O. Yuzhakov, P. Ramanathan, G. Ciaramella and A. Bukreyev
Most current Ebola virus (EBOV) vaccine candidates are based on viral vectors, some of which cause side effects or require complex manufacturing. Modified mRNA vaccines are easily produced, safe, and are highly immunogenic. We developed 2 mRNA vaccines based on the EBOV envelope ...
Read More
Publication - Abstract
Feb 04, 2020
npj Vaccines
N.A.C Jackson, K.E. Kester, D. Casimiro, S. Gurunathan and F. DeRosa
mRNA technologies have the potential to transform areas of medicine, including the prophylaxis of infectious diseases. The advantages for vaccines range from the acceleration of immunogen discovery to rapid response and multiple disease target manufacturing. A greater understandi...
Read More